Mitochondrial unfolded protein response as a central stress-integration hub: mechanisms and implications in disease contexts

Yanmin Xin , Yiting He , Xingguo Liu

Burns & Trauma ›› 2026, Vol. 14 ›› Issue (1) : tkag037

PDF (1537KB)
Burns & Trauma ›› 2026, Vol. 14 ›› Issue (1) :tkag037 DOI: 10.1093/burnst/tkag037
Review
research-article
Mitochondrial unfolded protein response as a central stress-integration hub: mechanisms and implications in disease contexts
Author information +
History +
PDF (1537KB)

Abstract

The mitochondrial unfolded protein response (UPRmt) is a conserved mitochondrial stress response that is activated by mitochondrial dysfunction to maintain proteostasis. Although UPRmt has been extensively studied in aging and cancer, its role in trauma and critical illness remains poorly understood. Here, we propose a unifying conceptual framework in which UPRmt functions as a central stress-integration hub that senses and coordinates adaptive responses following acute injury. We systematically review the mechanisms of UPRmt activation triggered by diverse insults and highlight how UPRmt integrates mitochondrial-nuclear communication, and crosstalk with other stress-responses such as the integrated stress response and mitophagy. Beyond cell-autonomous regulation, UPRmt also coordinates systemic adaptation through mitokine-mediated interorgan signaling. Importantly, we emphasize the context-dependent role of UPRmt in trauma and critical illness. Moderate activation promotes mitochondrial recovery, limits reactive oxygen species accumulation, and supports immune cell function, thereby enhancing tissue resilience and repair. In contrast, sustained or dysregulated UPRmt contributes to mitochondrial failure, sterile inflammation, and the progression to systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS). Furthermore, we discuss emerging evidence linking UPRmt to immune regulation and inflammatory responses, and propose that targeting key regulatory nodes within this stress-integration network may offer novel therapeutic strategies for a broad spectrum of human diseases. Crucially, we synthesize how UPRmt mechanisms contribute to post-traumatic mitochondrial damage, sterile inflammation, SIRS, and MODS. We propose that targeting key regulatory nodes within this stress-integration network may offer novel therapeutic strategies for trauma, burns, and critical illness.

Keywords

UPRmt / proteostasis / Trauma / Immunity / MODS / SIRS

Cite this article

Download citation ▾
Yanmin Xin, Yiting He, Xingguo Liu. Mitochondrial unfolded protein response as a central stress-integration hub: mechanisms and implications in disease contexts. Burns & Trauma, 2026, 14 (1) : tkag037 DOI:10.1093/burnst/tkag037

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Baker ZN, Forny P, Pagliarini DJ. Mitochondrial proteome research: the road ahead. Nat Rev Mol Cell Biol 2024; 25: 65-82. https://doi.org/10.1038/s41580-023-00650-7.

[2]

Hanada Y, Ishihara N, Wang L, Otera H, Ishihara T, Koshiba T, et al. MAVS is energized by Mff which senses mitochondrial metabolism via AMPK for acute antiviral immunity. Nat Commun 2020; 11: 5711. https://doi.org/10.1038/s41467-020-19287-7.

[3]

Xian H, Watari K, Sanchez-Lopez E, Offenberger J, Onyuru J, Sampath H, et al. Oxidized DNA fragments exit mitochondria via mPTP-and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity 2022; 55: 1370-85.e8. https://doi.org/10.1016/j.immuni.2022.06.007.

[4]

Fan M, Zhang J, Tsai CW, Orlando BJ, Rodriguez M, Xu Y, et al. Structure and mechanism of the mitochondrial Ca(2+) uniporter holocomplex. Nature 2020; 582: 129-33. https://doi.org/10.1038/s41586-020-2309-6.

[5]

Qiu J, Tan YW, Hagenston AM, Martel MA, Kneisel N, Skehel PA, et al. Mitochondrial calcium uniporter Mcu controls excitotoxicity and is transcriptionally repressed by neuroprotective nuclear calcium signals. Nat Commun 2013; 4: 2034. https://doi.org/10.1038/ncomms3034.

[6]

Ren X, Yan J, Zhao Q, Bao X, Han X, Zheng C, et al. The Fe-S cluster assembly protein IscU2 increases α-ketoglutarate catabolism and DNA 5mC to promote tumor growth. Cell Discov 2023; 9: 76. https://doi.org/10.1038/s41421-023-00558-8.

[7]

Lill R, Freibert SA. Mechanisms of mitochondrial iron-sulfur protein biogenesis. Annu Rev Biochem 2020; 89: 471-99. https://doi.org/10.1146/annurev-biochem-013118-111540.

[8]

Vringer E, Tait SWG. Mitochondria and cell death-associated inflammation. Cell Death Differ 2023; 30: 304-12. https://doi.org/10.1038/s41418-022-01094-w.

[9]

Saunders TL, Windley SP, Gervinskas G, Balka KR, Rowe C, Lane R, et al. Exposure of the inner mitochondrial membrane triggers apoptotic mitophagy. Cell Death Differ 2024; 31: 335-47. https://doi.org/10.1038/s41418-024-01260-2.

[10]

Mcgregor L, Acajjaoui S, Desfosses A, Saïdi M, Bacia-Verloop M, Schwarz JJ, et al. The assembly of the mitochondrial complex I assembly complex uncovers a redox pathway coordination. Nat Commun 2023; 14: 8248. https://doi.org/10.1038/s41467-023-43865-0.

[11]

Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X, et al. Mitochondrial diseases: from molecular mechanisms to therapeutic advances. Signal Transduct Target Ther 2025; 10: 9. https://doi.org/10.1038/s41392-024-02044-3.

[12]

Shpilka T, Haynes CM. The mitochondrial UPR: mechanisms, physiological functions and implications in ageing. Nat Rev Mol Cell Biol 2018; 19: 109-20. https://doi.org/10.1038/nrm.2017.110.

[13]

Tresse E, Marturia-Navarro J, Sew WQG, Cisquella-Serra M, Jaberi E, Riera-Ponsati L, et al. Mitochondrial DNA damage triggers spread of Parkinson’s disease-like pathology. Mol Psychiatry 2023; 28: 4902-14. https://doi.org/10.1038/s41380-023-02251-4.

[14]

Dölle C, Flønes I, Nido GS, Miletic H, Osuagwu N, Kristoffersen S, et al. Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease. Nat Commun 2016; 7: 13548. https://doi.org/10.1038/ncomms13548.

[15]

Geibl FF, Henrich MT, Xie Z, Zampese E, Ueda J, Tkatch T, et al. α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson’s disease. Mol Neurodegener 2024; 19: 69. https://doi.org/10.1186/s13024-024-00756-2.

[16]

Martinus RD, Garth GP, Webster TL, Cartwright P, Naylor DJ, Høj PB, et al. Selective induction of mitochondrial chaperones in response to loss of the mitochondrial genome. Eur J Biochem 1996; 240: 98-103. https://doi.org/10.1111/j.1432-1033.1996.0098h.x.

[17]

Ryan MT, Herd SM, Sberna G, Samuel MM, Hoogenraad NJ, Høj PB. The genes encoding mammalian chaperonin 60 and chaperonin 10 are linked head-to-head and share a bidirectional promoter. Gene 1997; 196: 9-17. https://doi.org/10.1016/S0378-1119(97)00111-X.

[18]

Zhao Q, Wang J, Levichkin IV, Stasinopoulos S, Ryan MT, Hoogenraad NJ. A mitochondrial specific stress response in mammalian cells. EMBO J 2002; 21: 4411-9. https://doi.org/10.1093/emboj/cdf445.

[19]

Katiyar A, Fujimoto M, Tan K, Kurashima A, Srivastava P, Okada M, et al. HSF1 is required for induction of mitochondrial chaperones during the mitochondrial unfolded protein response. FEBS Open Bio 2020; 10: 1135-48. https://doi.org/10.1002/2211-5463.12863.

[20]

Houtkooper RH, Mouchiroud L, Ryu D, Moullan N, Katsyuba E, Knott G, et al. Mitonuclear protein imbalance as a conserved longevity mechanism. Nature 2013; 497: 451-7. https://doi.org/10.1038/nature12188.

[21]

Zhang Q, Wang Z, Zhang W, Wen Q, Li X, Zhou J, et al. The memory of neuronal mitochondrial stress is inherited transgenerationally via elevated mitochondrial DNA levels. Nat Cell Biol 2021; 23: 870-80. https://doi.org/10.1038/s41556-021-00724-8.

[22]

Kinoshita M, Barber M, Mansfield W, Cui Y, Spindlow D, Stirparo GG, et al. Capture of mouse and human stem cells with features of formative pluripotency. Cell Stem Cell 2021; 28: 453-71.e8. https://doi.org/10.1016/j.stem.2020.11.005.

[23]

Shin CS, Meng S, Garbis SD, Moradian A, Taylor RW, Sweredoski MJ, et al. LONP1 and mtHSP70 cooperate to promote mitochondrial protein folding. Nat Commun 2021; 12: 265. https://doi.org/10.1038/s41467-020-20597-z.

[24]

Hsu MC, Kinefuchi H, Lei L, Kikuchi R, Yamano K, Youle RJ. Mitochondrial YME1L1 governs unoccupied protein translocase channels. Nat Cell Biol 2025; 27: 309-21. https://doi.org/10.1038/s41556-024-01571-z.

[25]

Münch C, Harper JW. Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation. Nature 2016; 534: 710-3. https://doi.org/10.1038/nature18302.

[26]

Ying Z, Xin Y, Liu Z, Tan T, Huang Y, Ding Y, et al. The mitochondrial unfolded protein response inhibits pluripotency acquisition and mesenchymal-to-epithelial transition in somatic cell reprogramming. Nat Metab 2025; 7: 940-51. https://doi.org/10.1038/s42255-025-01261-6.

[27]

Zhou Z, Lu J, Yang M, Cai J, Fu Q, Ma J, et al. The mitochondrial unfolded protein response (UPR(mt)) protects against osteoarthritis. Exp Mol Med 2022; 54: 1979-90. https://doi.org/10.1038/s12276-022-00885-y.

[28]

An H, Zhou B, Hayakawa K, Durán Laforet V, Park JH, Nakamura Y, et al. ATF5-mediated mitochondrial unfolded protein response (UPR(mt)) protects neurons against oxygen-glucose deprivation and cerebral ischemia. Stroke 2024; 55: 1904-13. https://doi.org/10.1161/STROKEAHA.123.045550.

[29]

Moullan N, Mouchiroud L, Wang X, Ryu D, Williams EG, Mottis A, et al. Tetracyclines disturb mitochondrial function across eukaryotic models: a call for caution in biomedical research. Cell Rep 2015; 10: 1681-91. https://doi.org/10.1016/j.celrep.2015.02.034.

[30]

Chatzispyrou IA, Held NM, Mouchiroud L, Auwerx J, Houtkooper RH. Tetracycline antibiotics impair mitochondrial function and its experimental use confounds research. Cancer Res 2015; 75: 4446-9. https://doi.org/10.1158/0008-5472.CAN-15-1626.

[31]

Forkink M, Basit F, Teixeira J, Swarts HG, Koopman WJH, Willems PHGM. Complex I and complex III inhibition specifically increase cytosolic hydrogen peroxide levels without inducing oxidative stress in HEK293 cells. Redox Biol 2015; 6: 607-16. https://doi.org/10.1016/j.redox.2015.09.003.

[32]

Zikaki K, Kiachaki E, Gaitanaki C, Aggeli IK. “Villains” turning good: antimycin a and rotenone, mitochondrial respiratory chain inhibitors, protect H9c2 cardiac cells against insults triggering the intrinsic apoptotic pathway. Int J Mol Sci 2025; 26: 2435. https://doi.org/10.3390/ijms26062435.

[33]

Bora S, Vardhan GSH, Deka N, Khataniar L, Gogoi D, Baruah A. Paraquat exposure over generation affects lifespan and reproduction through mitochondrial disruption in C. elegans. Toxicology 2021; 447: 152632. https://doi.org/10.1016/j.tox.2020.152632.

[34]

Wang B, Chen W, Huang Q, Chen Y, Wang Y. Targeting cancer mitochondria by inducing an abnormal mitochondrial unfolded protein response leads to tumor suppression. Int J Med Sci 2024; 21: 1204-12. https://doi.org/10.7150/ijms.95624.

[35]

Eiermann N, Stoecklin G, Jovanovic B. Mitochondrial inhibition by sodium azide induces assembly of eIF2α phosphorylation-independent stress granules in mammalian cells. Int J Mol Sci 2022; 23: 5600. https://doi.org/10.3390/ijms23105600.

[36]

Koncha RR, Ramachandran G, Sepuri NBV, Ramaiah KVA. CCCP-induced mitochondrial dysfunction-characterization and analysis of integrated stress response to cellular signaling and homeostasis. FEBS J 2021; 288: 5737-54. https://doi.org/10.1111/febs.15868.

[37]

Xin N, Durieux J, Yang C, Wolff S, Kim HE, Dillin A. The UPRmt preserves mitochondrial import to extend lifespan. J Cell Biol 2022; 221: e202201071. https://doi.org/10.1083/jcb.202201071.

[38]

Yoneda T, Benedetti C, Urano F, Clark SG, Harding HP, Ron D. Compartment-specific perturbation of protein handling activates genes encoding mitochondrial chaperones. J Cell Sci 2004; 117: 4055-66. https://doi.org/10.1242/jcs.01275.

[39]

Rolland SG, Schneid S, Schwarz M, Rackles E, Fischer C, Haeussler S, et al. Compromised mitochondrial protein import acts as a signal for UPR(mt). Cell Rep 2019; 28: 1659-69.e5. https://doi.org/10.1016/j.celrep.2019.07.049.

[40]

Zhang Q, Wu X, Chen P, Liu L, Xin N, Tian Y, et al. The mitochondrial unfolded protein response is mediated cell-non-autonomously by retromer-dependent Wnt signaling. Cell 2018; 174: 870-83.e17. https://doi.org/10.1016/j.cell.2018.06.029.

[41]

Durieux J, Wolff S, Dillin A. The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell 2011; 144: 79-91. https://doi.org/10.1016/j.cell.2010.12.016.

[42]

Bennett CF, Vander Wende H, Simko M, Klum S, Barfield S, Choi H, et al. Activation of the mitochondrial unfolded protein response does not predict longevity in Caenorhabditis elegans. Nat Commun 2014; 5: 3483. https://doi.org/10.1038/ncomms4483.

[43]

Mouchiroud L, Houtkooper RH, Moullan N, Katsyuba E, Ryu D, Cantó C, et al. The NAD(+)/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 2013; 154: 430-41. https://doi.org/10.1016/j.cell.2013.06.016.

[44]

Cerutti R, Pirinen E, Lamperti C, Marchet S, Sauve AA, Li W, et al. NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease. Cell Metab 2014; 19: 1042-9. https://doi.org/10.1016/j.cmet.2014.04.001.

[45]

Zhou S, Xiong X, Hou J, Duan Q, Zheng Y, Jiang T, et al. NAD+-boosters improve mitochondria quality control In Parkinson’s disease models via mitochondrial UPR. Adv Sci (Weinh) 2025; 12: e08503. https://doi.org/10.1002/advs.202408503.

[46]

Lautrup S, Sinclair DA, Mattson MP, Fang EF. NAD(+) in brain aging and neurodegenerative disorders. Cell Metab 2019; 30: 630-55. https://doi.org/10.1016/j.cmet.2019.09.001.

[47]

Xiong X, Hou J, Zheng Y, Jiang T, Zhao X, Cai J, et al. NAD(+)-boosting agent nicotinamide mononucleotide potently improves mitochondria stress response in Alzheimer’s disease via ATF4-dependent mitochondrial UPR. Cell Death Dis 2024; 15: 744. https://doi.org/10.1038/s41419-024-07062-1.

[48]

Yoshino J, Baur JA, Imai SI. NAD(+) intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab 2018; 27: 513-28. https://doi.org/10.1016/j.cmet.2017.11.002.

[49]

Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006; 127: 1109-22. https://doi.org/10.1016/j.cell.2006.11.013.

[50]

Pillai VB, Samant S, Sundaresan NR, Raghuraman H, Kim G, Bonner MY, et al. Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3. Nat Commun 2015; 6: 6656. https://doi.org/10.1038/ncomms7656.

[51]

Ryu D, Mouchiroud L, Andreux PA, Katsyuba E, Moullan N, Nicolet-dit-Félix AA, et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat Med 2016; 22: 879-88. https://doi.org/10.1038/nm.4132.

[52]

Puleston DJ, Buck MD, Klein Geltink RI, Kyle RL, Caputa G, O’Sullivan D, et al. Polyamines and eIF5A hypusination modulate mitochondrial respiration and macrophage activation. Cell Metab 2019; 30: 352-63.e8. https://doi.org/10.1016/j.cmet.2019.05.003.

[53]

Zhou J, Pang J, Tripathi M, Ho JP, Widjaja AA, Shekeran SG, et al. Spermidine-mediated hypusination of translation factor EIF5A improves mitochondrial fatty acid oxidation and prevents non-alcoholic steatohepatitis progression. Nat Commun 2022; 13: 5202. https://doi.org/10.1038/s41467-022-32788-x.

[54]

Rosenberger FA, Moore D, Atanassov I, Moedas MF, Clemente P, Végvári Á, et al. The one-carbon pool controls mitochondrial energy metabolism via complex I and iron-sulfur clusters. Sci Adv 2021; 7: eabf0717. https://doi.org/10.1126/sciadv.abf0717.

[55]

Fang W, Jiang L, Zhu Y, Yang S, Qiu H, Cheng J, et al. Methionine restriction constrains lipoylation and activates mitochondria for nitrogenic synthesis of amino acids. Nat Commun 2023; 14: 2504. https://doi.org/10.1038/s41467-023-38289-9.

[56]

Pellegrino MW, Nargund AM, Kirienko NV, Gillis R, Fiorese CJ, Haynes CM. Mitochondrial UPR-regulated innate immunity provides resistance to pathogen infection. Nature 2014; 516: 414-7. https://doi.org/10.1038/nature13818.

[57]

Tian Y, Garcia G, Bian Q, Steffen KK, Joe L, Wolff S, et al. Mitochondrial stress induces chromatin reorganization to promote longevity and UPR(mt). Cell 2016; 165: 1197-208. https://doi.org/10.1016/j.cell.2016.04.011.

[58]

Merkwirth C, Jovaisaite V, Durieux J, Matilainen O, Jordan SD, Quiros PM, et al. Two conserved histone demethylases regulate mitochondrial stress-induced longevity. Cell 2016; 165: 1209-23. https://doi.org/10.1016/j.cell.2016.04.012.

[59]

Shao LW, Peng Q, Dong M, Gao K, Li Y, Li Y, et al. Histone deacetylase HDA-1 modulates mitochondrial stress response and longevity. Nat Commun 2020; 11: 4639. https://doi.org/10.1038/s41467-020-18501-w.

[60]

Haynes CM, Petrova K, Benedetti C, Yang Y, Ron D. ClpP mediates activation of a mitochondrial unfolded protein response in C. elegans. Dev Cell 2007; 13: 467-80. https://doi.org/10.1016/j.devcel.2007.07.016.

[61]

Sheng Y, Abreu A, Markovich Z, Ebea P, Davis L, Park E, et al. A mitochondrial unfolded protein response-independent role of DVE-1 in longevity regulation. Cell Rep 2024; 43: 114889. https://doi.org/10.1016/j.celrep.2024.114889.

[62]

Liu H, Tian L, Qu M, Wang D. Acetylation regulation associated with the induction of protective response to polystyrene nanoparticles in Caenorhabditis elegans. J Hazard Mater 2021; 411: 125035. https://doi.org/10.1016/j.jhazmat.2020.125035.

[63]

Haynes CM, Yang Y, Blais SP, Neubert TA, Ron D. The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans. Mol Cell 2010; 37: 529-40. https://doi.org/10.1016/j.molcel.2010.01.015.

[64]

Nargund AM, Pellegrino MW, Fiorese CJ, Baker BM, Haynes CM. Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation. Science 2012; 337: 587-90. https://doi.org/10.1126/science.1223560.

[65]

Yang Q, Liu P, Anderson NS, Shpilka T, du YG, Naresh NU, et al. LONP-1 and ATFS-1 sustain deleterious heteroplasmy by promoting mtDNA replication in dysfunctional mitochondria. Nat Cell Biol 2022; 24: 181-93. https://doi.org/10.1038/s41556-021-00840-5.

[66]

Nargund AM, Fiorese CJ, Pellegrino MW, Deng P, Haynes CM. Mitochondrial and nuclear accumulation of the transcription factor ATFS-1 promotes OXPHOS recovery during the UPR(mt). Mol Cell 2015; 58: 123-33. https://doi.org/10.1016/j.molcel.2015.02.008.

[67]

Fiorese CJ, Schulz AM, Lin YF, Rosin N, Pellegrino MW, Haynes CM. The transcription factor ATF5 mediates a mammalian mitochondrial UPR. Curr Biol 2016; 26: 2037-43. https://doi.org/10.1016/j.cub.2016.06.002.

[68]

Sutandy FXR, Gößner I, Tascher G, Münch C. A cytosolic surveillance mechanism activates the mitochondrial UPR. Nature 2023; 618: 849-54. https://doi.org/10.1038/s41586-023-06142-0.

[69]

Li J, Deng Y, Gasser M, Zhu J, Walker EM, Sidarala V, et al. LONP1 regulation of mitochondrial protein folding provides insight into beta cell failure in type 2 diabetes. Nat Metab 2025; 7: 1570-92. https://doi.org/10.1038/s42255-025-01333-7.

[70]

Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010; 464: 121-5. https://doi.org/10.1038/nature08778.

[71]

Qiu X, Brown K, Hirschey MD, Verdin E, Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 2010; 12: 662-7. https://doi.org/10.1016/j.cmet.2010.11.015.

[72]

Cheng A, Yang Y, Zhou Y, Maharana C, Lu D, Peng W, et al. Mitochondrial SIRT3 mediates adaptive responses of neurons to exercise and metabolic and excitatory challenges. Cell Metab 2016; 23: 128-42. https://doi.org/10.1016/j.cmet.2015.10.013.

[73]

Clausen T, Kaiser M, Huber R, Ehrmann M. HTRA proteases: regulated proteolysis in protein quality control. Nat Rev Mol Cell Biol 2011; 12: 152-62. https://doi.org/10.1038/nrm3065.

[74]

Tan K, Fujimoto M, Takii R, Takaki E, Hayashida N, Nakai A. Mitochondrial SSBP1 protects cells from proteotoxic stresses by potentiating stress-induced HSF1 transcriptional activity. Nat Commun 2015; 6: 6580. https://doi.org/10.1038/ncomms7580.

[75]

Migliavacca E, Tay SKH, Patel HP, Sonntag T, Civiletto G, McFarlane C, et al. Mitochondrial oxidative capacity and NAD(+) biosynthesis are reduced in human sarcopenia across ethnicities. Nat Commun 2019; 10: 5808. https://doi.org/10.1038/s41467-019-13694-1.

[76]

Van Der Slikke EC, Star BS, Van Meurs M, Henning RH, Moser J, Bouma HR. Sepsis is associated with mitochondrial DNA damage and a reduced mitochondrial mass in the kidney of patients with sepsis-AKI. Crit Care 2021; 25: 36. https://doi.org/10.1186/s13054-020-03424-1.

[77]

Hirschberger S, Müller MB, Mascolo H, Seitz M, Nibler S, Effinger D, et al. Mitochondrial damage drives T-cell immunometabolic paralysis after major surgery. EMBO Mol Med 2025; 17: 3329-54. https://doi.org/10.1038/s44321-025-00324-1.

[78]

Zou R, Tao J, Qiu J, Lu H, Wu J, Zhu H, et al. DNA-PKcs promotes sepsis-induced multiple organ failure by triggering mitochondrial dysfunction. J Adv Res 2022; 41: 39-48. https://doi.org/10.1016/j.jare.2022.01.014.

[79]

Berendzen KM, Durieux J, Shao LW, Tian Y, Kim HE, Wolff S, et al. Neuroendocrine coordination of mitochondrial stress signaling and proteostasis. Cell 2016; 166: 1553-63.e10. https://doi.org/10.1016/j.cell.2016.08.042.

[80]

Shao LW, Niu R, Liu Y. Neuropeptide signals cell non-autonomous mitochondrial unfolded protein response. Cell Res 2016; 26: 1182-96. https://doi.org/10.1038/cr.2016.118.

[81]

Li J, Cui J, Li X, Zhu D, Chen Z, Huang X, et al. TMBIM-2 orchestrates systemic mitochondrial stress response via facilitating Ca2+ oscillations. J Cell Biol 2025; 224: e202408050. https://doi.org/10.1083/jcb.202408050.

[82]

Duarte JM, Schuck PF, Wenk GL, Ferreira GC. Metabolic disturbances in diseases with neurological involvement. Aging Dis 2014; 5: 238-55. https://doi.org/10.14336/AD.2014.0500238.

[83]

Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 2003; 11: 619-33. https://doi.org/10.1016/S1097-2765(03)00105-9.

[84]

Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 2000; 6: 1099-108. https://doi.org/10.1016/S1097-2765(00)00108-8.

[85]

Lu PD, Harding HP, Ron D. Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J Cell Biol 2004; 167: 27-33. https://doi.org/10.1083/jcb.200408003.

[86]

Baker BM, Nargund AM, Sun T, Haynes CM. Protective coupling of mitochondrial function and protein synthesis via the eIF2α kinase GCN-2. PLoS Genet 2012; 8: e1002760. https://doi.org/10.1371/journal.pgen.1002760.

[87]

Hekimi S, Lapointe J, Wen Y. Taking a “good” look at free radicals in the aging process. Trends Cell Biol 2011; 21: 569-76. https://doi.org/10.1016/j.tcb.2011.06.008.

[88]

Moisoi N, Klupsch K, Fedele V, East P, Sharma S, Renton A, et al. Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. Cell Death Differ 2009; 16: 449-64. https://doi.org/10.1038/cdd.2008.166.

[89]

Rainbolt TK, Atanassova N, Genereux JC, Wiseman RL. Stress-regulated translational attenuation adapts mitochondrial protein import through Tim17A degradation. Cell Metab 2013; 18: 908-19. https://doi.org/10.1016/j.cmet.2013.11.006.

[90]

Evstafieva AG, Garaeva AA, Khutornenko AA, Klepikova AV, Logacheva MD, Penin AA, et al. A sustained deficiency of mitochondrial respiratory complex III induces an apoptotic cell death through the p53-mediated inhibition of pro-survival activities of the activating transcription factor 4. Cell Death Dis 2014; 5: e1511. https://doi.org/10.1038/cddis.2014.469.

[91]

Lu HJ, Koju N, Sheng R. Mammalian integrated stress responses in stressed organelles and their functions. Acta Pharmacol Sin 2024; 45: 1095-114. https://doi.org/10.1038/s41401-023-01225-0.

[92]

Viader A, Sasaki Y, Kim S, Strickland A, Workman CS, Yang K, et al. Aberrant Schwann cell lipid metabolism linked to mitochondrial deficits leads to axon degeneration and neuropathy. Neuron 2013; 77: 886-98. https://doi.org/10.1016/j.neuron.2013.01.012.

[93]

Zhang W, Feng D, Li Y, Iida K, McGrath B, Cavener DR. PERK EIF2AK3 control of pancreatic beta cell differentiation and proliferation is required for postnatal glucose homeostasis. Cell Metab 2006; 4: 491-7. https://doi.org/10.1016/j.cmet.2006.11.002.

[94]

Guo F, Cavener DR. The GCN2 eIF2alpha kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid. Cell Metab 2007; 5: 103-14. https://doi.org/10.1016/j.cmet.2007.01.001.

[95]

Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 2015; 524: 309-14. https://doi.org/10.1038/nature14893.

[96]

Wang Y, Jasper H, Toan S, Muid D, Chang X, Zhou H. Mitophagy coordinates the mitochondrial unfolded protein response to attenuate inflammation-mediated myocardial injury. Redox Biol 2021; 45: 102049. https://doi.org/10.1016/j.redox.2021.102049.

[97]

Li FJ, Hu H, Wu L, Luo B, Zhou Y, Ren J, et al. Ablation of mitophagy receptor FUNDC1 accentuates septic cardiomyopathy through ACSL4-dependent regulation of ferroptosis and mitochondrial integrity. Free Radic Biol Med 2024; 225: 75-86. https://doi.org/10.1016/j.freeradbiomed.2024.09.039.

[98]

Wang J, Zhou H. Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia-reperfusion injury. Acta Pharm Sin B 2020; 10: 1866-79. https://doi.org/10.1016/j.apsb.2020.03.004.

[99]

Andreux PA, Blanco-Bose W, Ryu D, Burdet F, Ibberson M, Aebischer P, et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nat Metab 2019; 1: 595-603. https://doi.org/10.1038/s42255-019-0073-4.

[100]

Palikaras K, Lionaki E, Tavernarakis N. Coordination of mitophagy and mitochondrial biogenesis during ageing in C. elegans. Nature 2015; 521: 525-8. https://doi.org/10.1038/nature14300.

[101]

Burman JL, Pickles S, Wang C, Sekine S, Vargas JNS, Zhang Z, et al. Mitochondrial fission facilitates the selective mitophagy of protein aggregates. J Cell Biol 2017; 216: 3231-47. https://doi.org/10.1083/jcb.201612106.

[102]

López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell 2013; 153: 1194-217. https://doi.org/10.1016/j.cell.2013.05.039.

[103]

Wang CL, Ohkubo R, Mu WC, Chen W, Fan JL, Song Z, et al. The mitochondrial unfolded protein response regulates hippocampal neural stem cell aging. Cell Metab 2023; 35: 996-1008.e7. https://doi.org/10.1016/j.cmet.2023.04.012.

[104]

Xu WN, Zheng HL, Yang RZ, Sun YF, Peng BR, Liu C, et al. The mitochondrial UPR induced by ATF5 attenuates intervertebral disc degeneration via cooperating with mitophagy. Cell Biol Toxicol 2024; 40: 16. https://doi.org/10.1007/s10565-024-09854-9.

[105]

López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell 2023; 186: 243-78. https://doi.org/10.1016/j.cell.2022.11.001.

[106]

Hu IM, Molenaars M, Jaspers YRJ, Schomakers BV, van Weeghel M, Bakker A, et al. Immuno-metabolic stress responses control longevity from mitochondrial translation inhibition in C. elegans. Nat Commun 2025; 16: 6083. https://doi.org/10.1038/s41467-025-61433-6.

[107]

Sun N, Youle RJ, Finkel T. The mitochondrial basis of aging. Mol Cell 2016; 61: 654-66. https://doi.org/10.1016/j.molcel.2016.01.028.

[108]

Miwa S, Kashyap S, Chini E, von Zglinicki T. Mitochondrial dysfunction in cell senescence and aging. J Clin Invest 2022; 132: e158447. https://doi.org/10.1172/JCI158447.

[109]

Wiley CD, Velarde MC, Lecot P, Liu S, Sarnoski EA, Freund A, et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab 2016; 23: 303-14. https://doi.org/10.1016/j.cmet.2015.11.011.

[110]

Gariani K, Menzies KJ, Ryu D, Wegner CJ, Wang X, Ropelle ER, et al. Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice. Hepatology 2016; 63: 1190-204. https://doi.org/10.1002/hep.28245.

[111]

Escalante-Covarrubias Q, Mendoza-Viveros L, González-Suárez M, Sitten-Olea R, Velázquez-Villegas LA, Becerril-Pérez F, et al. Time-of-day defines NAD(+) efficacy to treat diet-induced metabolic disease by synchronizing the hepatic clock in mice. Nat Commun 2023; 14: 1685. https://doi.org/10.1038/s41467-023-37286-2.

[112]

Canto C, Menzies KJ, Auwerx J. NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab 2015; 22: 31-53. https://doi.org/10.1016/j.cmet.2015.05.023.

[113]

Zhang H, Ryu D, Wu Y, Gariani K, Wang X, Luan P, et al. NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science 2016; 352: 1436-43. https://doi.org/10.1126/science.aaf2693.

[114]

Yang L, Ruan Z, Lin X, Wang H, Xin Y, Tang H, et al. NAD(+) dependent UPR(mt) activation underlies intestinal aging caused by mitochondrial DNA mutations. Nat Commun 2024; 15: 546. https://doi.org/10.1038/s41467-024-44808-z.

[115]

Ying Z, Xiang G, Zheng L, Tang H, Duan L, Lin X, et al. Short-term mitochondrial permeability transition pore opening modulates histone lysine methylation at the early phase of somatic cell reprogramming. Cell Metab 2018; 28: 935-45.e5. https://doi.org/10.1016/j.cmet.2018.08.001.

[116]

Wen YA, Xiong X, Scott T, Li AT, Wang C, Weiss HL, et al. The mitochondrial retrograde signaling regulates Wnt signaling to promote tumorigenesis in colon cancer. Cell Death Differ 2019; 26: 1955-69. https://doi.org/10.1038/s41418-018-0265-6.

[117]

Cerqua M, Foiani M, Boccaccio C, Comoglio PM, Altintas DM. The integrated stress response drives MET oncogene overexpression in cancers. EMBO J 2025; 44: 1107-30. https://doi.org/10.1038/s44318-024-00338-4.

[118]

Wang SF, Tseng LM, Lee HC. Role of mitochondrial alterations in human cancer progression and cancer immunity. J Biomed Sci 2023; 30: 61. https://doi.org/10.1186/s12929-023-00956-w.

[119]

Kenny TC, Craig AJ, Villanueva A, Germain D. Mitohormesis primes tumor invasion and metastasis. Cell Rep 2019; 27: 2292-303.e6. https://doi.org/10.1016/j.celrep.2019.04.095.

[120]

Kang YE, Kim JM, Lim MA, Lee SE, Yi S, Kim JT, et al. Growth differentiation factor 15 is a cancer cell-induced mitokine that primes thyroid cancer cells for invasiveness. Thyroid 2021; 31: 772-86. https://doi.org/10.1089/thy.2020.0034.

[121]

Inigo JR, Chandra D . The mitochondrial unfolded protein response (UPR(mt)): shielding against toxicity to mitochondria in cancer. J Hematol Oncol 2022; 15: 98. https://doi.org/10.1186/s13045-022-01317-0.

[122]

Du H, Xu T, Yu S, Wu S, Zhang J. Mitochondrial metabolism and cancer therapeutic innovation. Signal Transduct Target Ther 2025; 10: 245. https://doi.org/10.1038/s41392-025-02311-x.

[123]

Li L, Pan D, Ai R, Zhou Y. Mitochondria-associated pathways in cancer and precancerous conditions: mechanistic insights. Int J Mol Sci 2025; 26: 8537. https://doi.org/10.3390/ijms26178537.

[124]

Kuo CL, Ponneri Babuharisankar A, Lin YC, Lien HW, Lo YK, Chou HY, et al. Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend? J Biomed Sci 2022; 29: 74. https://doi.org/10.1186/s12929-022-00859-2.

[125]

Sainero-Alcolado L, Liaño-Pons J, Ruiz-Pérez MV, Arsenian-Henriksson M. Targeting mitochondrial metabolism for precision medicine in cancer. Cell Death Differ 2022; 29: 1304-17. https://doi.org/10.1038/s41418-022-01022-y.

[126]

Zhu L, Luo X, Fu N, Chen L. Mitochondrial unfolded protein response: a novel pathway in metabolism and immunity. Pharmacol Res 2021; 168: 105603. https://doi.org/10.1016/j.phrs.2021.105603.

[127]

Rath E, Berger E, Messlik A, Nunes T, Liu B, Kim SC, et al. Induction of dsRNA-activated protein kinase links mitochondrial unfolded protein response to the pathogenesis of intestinal inflammation. Gut 2012; 61: 1269-78. https://doi.org/10.1136/gutjnl-2011-300767.

[128]

Kim S, Ramalho TR, Haynes CM. Regulation of proteostasis and innate immunity via mitochondria-nuclear communication. J Cell Biol 2024; 223: e202310005. https://doi.org/10.1083/jcb.202310005.

[129]

Haileselassie B, Mukherjee R, Joshi AU, Napier BA, Massis LM, Ostberg NP, et al. Drp1/Fis1 interaction mediates mitochondrial dysfunction in septic cardiomyopathy. J Mol Cell Cardiol 2019; 130: 160-9. https://doi.org/10.1016/j.yjmcc.2019.04.006.

[130]

Huang J, Peng W, Zheng Y, Hao H, Li S, Yao Y, et al. Upregulation of UCP2 expression protects against LPS-induced oxidative stress and apoptosis in cardiomyocytes. Oxidative Med Cell Longev 2019; 2019: 1-10. https://doi.org/10.1155/2019/2758262.

[131]

Rodríguez-Nuevo A, Zorzano A . The sensing of mitochondrial DAMPs by non-immune cells. Cell Stress 2019; 3: 195-207. https://doi.org/10.15698/cst2019.06.190.

[132]

Newman LE, Shadel GS. Mitochondrial DNA release in innate immune signaling. Annu Rev Biochem 2023; 92: 299-332. https://doi.org/10.1146/annurev-biochem-032620-104401.

[133]

Iyer SS, He Q, Janczy JR, Elliott EI, Zhong Z, Olivier AK, et al. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 2013; 39: 311-23. https://doi.org/10.1016/j.immuni.2013.08.001.

[134]

Dela Cruz CS, Kang MJ. Mitochondrial dysfunction and damage associated molecular patterns (DAMPs) in chronic inflammatory diseases. Mitochondrion 2018; 41: 37-44. https://doi.org/10.1016/j.mito.2017.12.001.

[135]

Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010; 10: 826-37. https://doi.org/10.1038/nri2873.

[136]

Roh JS, Sohn DH. Damage-associated molecular patterns in inflammatory diseases. Immune Netw 2018; 18: e27. https://doi.org/10.4110/in.2018.18.e27.

[137]

Shen L, Gan Q, Yang Y, Reis C, Zhang Z, Xu S, et al. Mitophagy in cerebral ischemia and ischemia/reperfusion injury. Front Aging Neurosci 2021; 13: 687246. https://doi.org/10.3389/fnagi.2021.687246.

[138]

Fei M, Xu Y, Jin P, Wang Y, Zhou M. Mitochondrial dysfunction in sepsis-induced liver injury: from pathophysiology to preclinical therapeutic targets. J Transl Med 2025; 23: 1339. https://doi.org/10.1186/s12967-025-07369-3.

[139]

Zhang X, Sun Y, Yang R, Liu B, Liu Y, Yang J, et al. An injectable mitochondria-targeted nanodrug loaded-hydrogel for restoring mitochondrial function and hierarchically attenuating oxidative stress to reduce myocardial ischemia-reperfusion injury. Biomaterials 2022; 287: 121656. https://doi.org/10.1016/j.biomaterials.2022.121656.

[140]

Kadier T, Zhang YG, Jing YX, Weng ZY, Liao SS, Luo J, et al. MCU inhibition protects against intestinal ischemia-reperfusion by inhibiting Drp1-dependent mitochondrial fission. Free Radic Biol Med 2024; 221: 111-24. https://doi.org/10.1016/j.freeradbiomed.2024.05.024.

[141]

Huang J, Chen L, Yao ZM, Sun XR, Tong XH, Dong SY. The role of mitochondrial dynamics in cerebral ischemia-reperfusion injury. Biomed Pharmacother 2023; 162: 114671. https://doi.org/10.1016/j.biopha.2023.114671.

[142]

Duan Y, Yang F, Zhang Y, Zhang M, Shi Y, Lang Y, et al. Role of mitophagy in spinal cord ischemia-reperfusion injury. Neural Regen Res 2026; 21: 598-611. https://doi.org/10.4103/NRR.NRR-D-24-00668.

[143]

Liao S, Luo J, Kadier T, Ding K, Chen R, Meng Q. Mitochondrial DNA release contributes to intestinal ischemia/reperfusion injury. Front Pharmacol 2022; 13: 854994. https://doi.org/10.3389/fphar.2022.854994.

[144]

Aswani A, Manson J, Itagaki K, Chiazza F, Collino M, Wupeng WL, et al. Scavenging circulating mitochondrial DNA as a potential therapeutic option for multiple organ dysfunction in trauma hemorrhage. Front Immunol 2018; 9: 891. https://doi.org/10.3389/fimmu.2018.00891.

[145]

Zhang Y, Li X, Zhao R, Hu W, Xiao X, Xiao Y, et al. Mitochondrial UPR is required for resveratrol mediated anti-bacterial immunity. Food Funct 2025; 16: 8604-15. https://doi.org/10.1039/D5FO03539B.

[146]

Zhou Z, Fan Y, Zong R, Tan K. The mitochondrial unfolded protein response: a multitasking giant in the fight against human diseases. Ageing Res Rev 2022; 81: 101702. https://doi.org/10.1016/j.arr.2022.101702.

[147]

Chen X, An H, He J, Guo J, Xu S, Wu C, et al. Mitochondrial unfolded protein response (UPR(mt)) as novel therapeutic targets for neurological disorders. J Cereb Blood Flow Metab 2026; 46: 333-49. https://doi.org/10.1177/0271678X251341293.

[148]

Wang G, Fan Y, Cao P, Tan K. Insight into the mitochondrial unfolded protein response and cancer: opportunities and challenges. Cell Biosci 2022; 12: 18. https://doi.org/10.1186/s13578-022-00747-0.

[149]

Torres AK, Fleischhart V, Inestrosa NC. Mitochondrial unfolded protein response (UPR(mt)): what we know thus far. Front Cell Dev Biol 2024; 12: 1405393. https://doi.org/10.3389/fcell.2024.1405393.

PDF (1537KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉